SCHEMBL31638393

SCHEMBL31638393

Nc1ncc(-c2ccccc2)nc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 6/20 0.51
PRKDC P78527 1/20 0.49
TLR9 Q9NR96 1/20 0.49
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ADORA2A P29274 2/20 0.44
AURKA O14965 1/20 0.44
HSP90AA1 P07900 1/20 0.44
PRKACA P17612 1/20 0.44
ADORA1 P30542 1/20 0.44
NEK2 P51955 1/20 0.43
MAPKAPK2 P49137 1/20 0.43
NPC1 O15118 1/20 0.43
PDGFRB P09619 1/20 0.43
KDR P35968 1/20 0.43
FLT3 P36888 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL934804 1.00 ATR (0.51) ATRPRKDCTLR9KDM4EMAPT
SCHEMBL23649366 0.85 TLR9 (0.49) ATRPRKDCTLR9KDM4EMAPT
SCHEMBL21266835 0.82 ATR (0.56) ATRMAPK1HSP90AA1
SCHEMBL29519952 0.82 ATR (0.56) ATRPRKDCTLR9MAPK1ADORA2A
SCHEMBL12489014 0.82 ATR (0.56) ATRPRKDCTLR9MAPK1ADORA2A
SCHEMBL5321269 0.81 NPC1 (0.50) ATRKDM4EMAPTL3MBTL1ADORA2A
SCHEMBL5320194 0.81 ATR (0.48) ATRKDM4EMAPK1L3MBTL1ADORA2A
SCHEMBL12198422 0.81 ATR (0.48) ATRKDM4EMAPTADORA2AADORA1
SCHEMBL23064174 0.81 PIK3CG (0.54) ATRPRKDCMAPTMAPK1
SCHEMBL27983733 0.81 ATR (0.36) ATRPRKDCTLR9ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206747-A1 COELENTERAZINE ANALOGUES PROMEGA CORPORATION 2025-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206747-A1 COELENTERAZINE ANALOGUES GLB1, AADAC, SI ATR 4766/4885PRKDC 4336/4885TLR9 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.